First Interstate Bank’s Meridian Bioscience Inc VIVO Stock Holding History

First Interstate Bank’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-200	Closed	-$4K	–	748
2016 Q4	$4K	Hold	200	–	–	﹤0.01%	662
2016 Q3	$4K	Hold	200	–	–	﹤0.01%	683
2016 Q2	$4K	Hold	200	–	–	﹤0.01%	663
2016 Q1	$4K	Hold	200	–	–	﹤0.01%	668
2015 Q4	$4K	Hold	200	–	–	﹤0.01%	687
2015 Q3	$3K	Buy	+200	New	+$3.65K	﹤0.01%	739

Other funds holding VIVO

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

First Interstate Bank's VIVO Position: Q1 2017 in Review

First Interstate Bank sold out of Meridian Bioscience Inc (VIVO) in Q1 2017, closing a stake of 200 shares — an estimated $4K sold.

First Interstate Bank first reported a position in VIVO in Q3 2015 and held it in 6 quarters. The position peaked at $4K in Q4 2016. 165 funds tracked by Wall St. Rank hold VIVO as of Q1 2017.

First Interstate Bank reported no remaining Meridian Bioscience Inc position as of Q1 2017 after selling out during the quarter.
First Interstate Bank sold 200 Meridian Bioscience Inc shares in Q1 2017, an estimated $4K.
First Interstate Bank first reported a position in Meridian Bioscience Inc in Q3 2015 and held it in 6 quarters.
First Interstate Bank's Meridian Bioscience Inc position peaked at $4K in Q4 2016.
165 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2017.

Based on First Interstate Bank's 13F filing for Q1 2017, filed 11 May 2017.